 - Patients expected to undergo a first course of a chemotherapy regimen during the study period, patients who received a vinca alkaloid within 2 months, patients who have any history of vinca-associated GI autonomic neuropathy andor constipation, or patients receiving a chemotherapy regimen including a VEGF-inhibitor e.g., bevacizumab, sorafenib. 